SMARTFINANCIAL INC.
For the period ended Dec 31, 2025. Filed Mar 16, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 16, 2026
SMBK$48.10-0.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
| | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|
| · · 2025 · · 2024 · · 2023 · | ||||||||||
| Cash flows from operating activities: · · · · · · · · | ||||||||||
| Net income | | $50,347 | | $36,141 | | $28,593 | | |||
| Adjustments to reconcile net income to net cash provided by operating activities: | | | | | | | | |||
| Depreciation and amortization | | 7,590 | | 8,990 | | 10,874 | | |||
| Amortization of intangible assets | | | 2,150 | | | 2,425 | | | 2,624 | |
| Provision for credit losses | | 7,750 | | 5,153 | | 3,029 | | |||
| Stock compensation expense | | 1,939 | | 1,629 | | 1,349 | | |||
| Net (gain) loss on sale of securities available-for-sale | | 3,719 | | (64) | | 6,801 | | |||
| Deferred income tax (benefit) expense | | (470) | | 120 | | 1,309 | | |||
| Increase in cash surrender value of bank-owned life insurance | | (3,608) | | (2,483) | | (1,964) | | |||
| Net losses from sale and write-downs of other real estate owned and other repossessed assets | | 632 | | 994 | | 78 | | |||
| Net gains from mortgage banking | | (2,565) | | (1,463) | | (1,040) | | |||
| Origination of loans held for sale | | (44,240) | | (49,845) | | (45,891) | | |||
| Proceeds from sales of loans held for sale | | 41,936 | | 49,730 | | 44,265 | | |||
| Gain from sale of SBKI | | | (3,955) | | | — | | | — | |
| Net loss (gain) from sale/disposal of fixed assets | | | 14 | | | (1,647) | | | 19 | |
| Net change in: | | | | | | | | |||
| Accrued interest receivable | | (1,450) | | (898) | | (2,989) | | |||
| Accrued interest payable | | 3,425 | | 250 | | 2,520 | | |||
| Other assets | | 4,114 | | 3,788 | | (1,732) | | |||
| Other liabilities | | (5,604) | | (120) | | (8,129) | | |||
| Net cash provided by operating activities | | 61,724 | | 52,700 | | 39,716 | | |||
| Cash flows from investing activities: | | | | | | | | |||
| Available-for-sale: | | | | | | | | | | |
| Proceeds from sales | | 99,966 | | — | | 152,775 | | |||
| Proceeds from maturities, calls and paydowns | | 72,289 | | 57,985 | | 56,273 | | |||
| Purchases | | | (215,345) | | | (131,376) | | | (130,584) | |
| Held-to-maturity: | | | | | | | | | | |
| Proceeds from maturities, calls and paydowns | | | 2,474 | | | 152,486 | | | 2,494 | |
| Proceeds from sales of other investments | | | 1,041 | | | 5,960 | | | 2,812 | |
| Purchases of other investments | | (6,319) | | (7,407) | | (944) | | |||
| Purchases of bank-owned life insurance | | | — | | | (30,000) | | | — | |
| Proceeds from sale of SBKI, net of transaction cost | | | 11,200 | | | — | | | — | |
| Net increase in loans and leases | | (464,342) | | (469,247) | | (213,591) | | |||
| Proceeds from sale of fixed assets | | | 123 | | | 4,698 | | | 682 | |
| Purchases of premises and equipment | | (2,389) | | (6,405) | | (6,270) | | |||
| Proceeds from sale of other real estate owned and other repossessed assets | | 2,254 | | 3,084 | | 1,113 | | |||
| Net cash used in investing activities | | (499,048) | | (420,222) | | (135,240) | | |||
| Cash flows from financing activities: | | | | | | | | |||
| Net increase in deposits | | 466,338 | | 418,696 | | 190,887 | | |||
| Net increase (decrease) in securities sold under agreements to repurchase | | (1,126) | | (944) | | 303 | | |||
| Proceeds from borrowings | | 2,500 | | 160,100 | | 26,275 | | |||
| Repayment of borrowings | | | (6,500) | | | (166,600) | | | (30,775) | |
| Cash dividends paid | | (5,452) | | (5,422) | | (5,427) | | |||
| Issuance of preferred stock of subsidiary - non-controlling interest, net of fees | | | — | | | 113 | | | — | |
| Redemption of subordinated debt | | | (40,000) | | | — | | | — | |
| Issuance of subordinated debt, net of issuance costs | | | 98,566 | | | — | | | — | |
| Issuance of common stock | | 153 | | 68 | | 165 | | |||
| Restricted shares withheld for taxes | | | (308) | | | (223) | | | (57) | |
| Repurchases of common stock | | — | | (2,967) | | — | | |||
| Net cash provided by financing activities | | 514,171 | | 402,821 | | 181,371 | | |||
| Net change in cash and cash equivalents | | 76,847 | | 35,299 | | 85,847 | | |||
| Cash and cash equivalents, beginning of period | | 387,570 | | 352,271 | | 266,424 | | |||
| Cash and cash equivalents, end of period | | $464,417 | | $387,570 | | $352,271 | | |||
| Supplemental disclosures of cash flow information: | | | | | | | | |||
| Cash paid during the period for interest | | $116,443 | | $113,665 | | $85,443 | | |||
| Net cash paid during the period for income taxes | | 12,390 | | 8,774 | | 9,347 | | |||
| Noncash investing and financing activities: | | | | | | | | |||
| Recognition of operating lease assets in exchange for lease liabilities | | | 790 | | | 3,573 | | | 1,751 | |
| Acquisition of real estate through foreclosure | | — | | 179 | | 272 | | |||
| Acquisition of other repossessed assets | | | 3,918 | | | 4,396 | | | — | |
| Financed sales of other repossessed assets | | | 1,433 | | | 1,132 | | | — | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.